Fennec Pharmaceuticals Inc.FENCNASDAQ

Revenue (LTM)

$48M

+123.7% YoY

Net Income (LTM)

$-436000

+97.3% YoY

Free Cash Flow

$27M

Revenue CAGR (5Y)

—

Marginsdeclining

FCFTurned positive

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	1	21↑1341.6%	48↑123.7%
Gross Profit	0	0	1	20↑1336.7%	44↑121.8%
Operating Income	-18	-17↑4.5%	-22↓27.1%	-13↑41.1%	3↑120.1%
Net Income	-18	-17↑5.1%	-23↓32.5%	-16↑29.5%	-0↑97.3%
EBITDA	0	-17	-22↓27.1%	-12↑43.0%	5↑138.8%
EPS Diluted	-0.76	-0.67↑11.8%	-0.95↓41.8%	-0.60↑36.8%	-0.02↑97.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	30	21↓30.5%	24↑12.7%	13↓44.2%	27↑100.7%
Total Current Assets	31	22↓28.7%	27↑19.4%	27↑0.5%	44↑64.3%
Total Assets	31	22↓28.7%	27↑20.2%	27↓0.3%	45↑67.3%
Total Current Liabilities	2	2↓29.5%	5↑178.7%	8↑63.9%	7↓8.4%
Total Liabilities	2	7↑183.0%	30↑344.3%	38↑30.4%	51↑32.0%
Total Equity	29	16↓45.7%	-3↓116.3%	-12↓352.4%	-6↑49.5%
Total Debt	0	5	25↑399.2%	31↑24.3%	19↓37.5%
Net Debt	-30	-16↑46.9%	1↑107.0%	18↑1472.0%	-7↓141.2%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-16	-14↑8.8%	-18↓27.0%	-17↑5.1%	27↑257.4%
Capital Expenditure	0	0	0	0	0
Free Cash Flow	-16	-14↑8.8%	-18↓27.0%	-17↑5.1%	27↑257.4%
Stock-Based Comp	3	4↑43.9%	4↑5.1%	5↑26.9%	5↓5.5%
Net Change in Cash	17	-9↓155.4%	3↑128.9%	-11↓492.9%	13↑227.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance